Get started
Author

Manuel Sureda

Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years’ experience of a new centre for peritoneal surface malignancies
2010 · Pedro Bretcha-Boix, Jose Farré-Alegre, et al. · Clinical & Translational Oncology · 32
Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies
2022 · Juan J. Mata-Molanes, Joseba Rebollo-Liceaga, et al. · Frontiers in Oncology · 27
PDF
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study
2019 · Manuel Ruíz-Borrego, Angel Guerrero-Zotano, et al. · Breast Cancer Research and Treatment · 23
Photodynamic therapy in the treatment of brain tumours. A feasibility study
2015 · Vicente Vanaclocha, Manuel Sureda, et al. · Photodiagnosis and Photodynamic Therapy · 21
Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study
2022 · Vanesa Escudero-Ortiz, Vanessa Domínguez-Leñero, et al. · Pharmaceutics · 20
PDF
Pharmacokinetic and Pharmacodynamic Analysis of Hyperthermic Intraperitoneal Oxaliplatin-Induced Neutropenia in Subjects with Peritoneal Carcinomatosis
2011 · Belén Valenzuela, Ricardo Nalda-Molina, et al. · The AAPS Journal · 20
PDF
Fixed higher dose schedule of suramin plus hydrocortisone in patients with hormone refractory prostate carcinoma
2001 · Emiliano Calvo, Javier Cort�s, et al. · Cancer · 19
PDF
Psycho-Oncological Intervention Through Counseling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine (COUNTHY, NCT05054634): A Non-randomized Controlled Study
2022 · Nuria Javaloyes, Aurora Crespo, et al. · Frontiers in Psychology · 14
PDF
Células dendríticas I: aspectos básicos de su biología y funciones
2011 · M. Begoña Vázquez, Manuel Sureda, et al. · Inmunología · 14
Gene Expression Profiling of Tumors From Heavily Pretreated Patients With Metastatic Cancer for the Selection of Therapy
2014 · Joseba Rebollo, Manuel Sureda, et al. · American Journal of Clinical Oncology · 9
Dosage of anti-PD-1 monoclonal antibodies: a cardinal open question
2021 · M. Sureda, E. Calvo, et al. · Clinical & Translational Oncology · 7
Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs)
2011 · Elena María Martínez-Navarro, Joseba Rebollo, et al. · Clinical & Translational Oncology · 7
A novel genomic signature predicting FDG uptake in diverse metastatic tumors
2018 · Aurora Crespo-Jara, Maria Carmen Redal-Peña, et al. · EJNMMI Research · 6
PDF
Carcinomatosis peritoneal: Quimioterapia intraperitoneal con hipertermia
2004 · J. Farré Alegre, P. Bretcha Boix, et al. · Oncología (Barcelona) · 6
PDF
Therapeutic Drug Monitoring of Erlotinib in Non-Small Cell Lung Carcinoma: A Case Study
2021 · Ana Catalán-Latorre, Manuel Sureda, et al. · Therapeutic Drug Monitoring · 4
High dose chemotherapy with peripheral blood stem cell (PBSC) support in solid tumours: preliminary results.
1990 · S Martín Algarra, M Sureda, et al. · PubMed · 3
Determining personalized treatment by gene expression profiling in metastatic breast carcinoma patients: a pilot study
2017 · M. Sureda, J. Rebollo, et al. · Clinical & Translational Oncology · 2
Therapeutic drug monitoring of nivolumab in clinical practice: Preliminary experience.
2019 · Manuel Sureda, Ana Catalán-Latorre, et al. · Journal of Clinical Oncology · 1
Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKI) in routine practice in an oncology service. preliminary results.
2018 · Manuel Sureda, Vanessa Dominguez, et al. · Journal of Clinical Oncology · 1
Quimioterapia intra-arterial hepática en las metástasis del carcinoma colorrectal
2017 · O. F. Hidalgo, A. C. Gil, et al. · Revista de medicina de la Universidad de Navarra · 1
A phase II study of Recchia's immunomodulatory schedule (RIS) as a maintenance therapy in high-risk tumors after a response.
2013 · Manuel Sureda, Joseba Rebollo, et al. · Journal of Clinical Oncology · 1
Células dendríticas II: utilización clínica en vacunación antitumoral
2012 · Manuel Sureda, M. Begoña Vázquez, et al. · Inmunología · 1
Total estrogen blockade (TEB) plus adjuvant chemotherapy in high-risk estrogen receptor-positive (ER+) premenopausal breast cancer: Long term results of an ovarian protection study
2008 · F. Recchia, G. Candeloro, et al. · Journal of Clinical Oncology · 1
Bone-targeted therapy in advanced androgen-independent prostate carcinoma: A feasibility study
2005 · A. Crespo, M. Sureda, et al. · Journal of Clinical Oncology · 1
Immunological profile could be responsible of the unusual long-lasting cutaneous-only breast cancer recurrence: An observational study.
2022 · Joseba Rebollo, Ramón González-Manzano, et al. · Journal of Clinical Oncology
Works count: 56
Citation count: 241
H-index: 9
I10-index: 9
Year
Topic
Type